Literature DB >> 3254982

Pharmacokinetics of cefpiramide in rats with obstructive jaundice.

T Kimura1, T Yamao, S Nakayama, S Honge, T Kawakami, Y Kurosaki, T Nakayama.   

Abstract

Changes in the mode of drug excretion in obstructive jaundice (OJ) were investigated in rats with experimentally induced OJ using a non-metabolized, highly-biliary-excreted antibiotic, cefpiramide (CPM). In OJ rats, biliary excretion of the drug was markedly diminished, while the urinary excretion was increased. The change in the mode of CPM excretion was examined in detail. It seems that the biliary excretion of CPM was decreased owing to the diminished biliary clearance in OJ rats. On the other hand, CPM binding to plasma proteins was decreased in the disease state. This change in the protein binding would be due to both the decreased albumin concentration and the accumulation of binding inhibitors in the plasma of diseased rats, and the decreased protein binding would be related not only to the increase in the volume of distribution but also to the increase in the renal clearance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3254982     DOI: 10.1248/bpb1978.11.839

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  4 in total

1.  Analysis of hepatic transport of cefpiramide in rats with obstructive jaundice by using isolated hepatocytes.

Authors:  T Yamao; S Nakayama; Y Kurosaki; T Nakayama; T Kimura
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

2.  Cefpiramide kinetics and plasma protein binding in cholestasis.

Authors:  F Demontes-Mainard; G Vinçon; L Labat; M Amouretti; J Necciari; G Kieffer; B Bannwarth
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

3.  Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats.

Authors:  I Muraoka; T Hasegawa; M Nadai; L Wang; S Haghgoo; O Tagaya; T Nabeshima
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

4.  Influence of obstructive jaundice on pharmacodynamics of rocuronium.

Authors:  Zhen-Meng Wang; Peng Zhang; Mi-Jia Lin; Bo Tan; Hai-Bo Qiu; Wei-Feng Yu
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.